Genetic variants inSLC22A17 and SLC22A7are associated with anthracycline-induced cardiotoxicity in children
about
Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis.Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.Exome array analysis identifies ETFB as a novel susceptibility gene for anthracycline-induced cardiotoxicity in cancer patients.Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines.Systematic review of pharmacogenomics and adverse drug reactions in paediatric oncology patients.
P2860
Genetic variants inSLC22A17 and SLC22A7are associated with anthracycline-induced cardiotoxicity in children
description
scientific article published on 31 July 2015
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2015
@uk
name
Genetic variants inSLC22A17 an ...... ced cardiotoxicity in children
@en
Genetic variants inSLC22A17 an ...... ced cardiotoxicity in children
@nl
type
label
Genetic variants inSLC22A17 an ...... ced cardiotoxicity in children
@en
Genetic variants inSLC22A17 an ...... ced cardiotoxicity in children
@nl
prefLabel
Genetic variants inSLC22A17 an ...... ced cardiotoxicity in children
@en
Genetic variants inSLC22A17 an ...... ced cardiotoxicity in children
@nl
P2093
P2860
P356
P1433
P1476
Genetic variants in SLC22A17 a ...... ced cardiotoxicity in children
@en
P2093
Bruce C Carleton
CPNDS consortium
Colin J Ross
Elvira C van Dalen
Helena J van der Pal
Henk Visscher
Huib N Caron
Leontien C Kremer
Michael J Rieder
Michael R Hayden
P2860
P304
P356
10.2217/PGS.15.61
P577
2015-07-31T00:00:00Z